Developer docs
API playgroundTry for free, no card

Search company profiles

IrisVision

Full company profile

uuid0002voh

Namestring
IrisVision
Legal namestring
IrisVision Global, Inc.
Websiteurl
irisvision.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

IrisVision Global, Inc. is a privately held medical-device company headquartered in Pleasanton, California, that develops FDA-registered Class I wearable headsets for individuals with low vision caused by conditions such as macular degeneration, diabetic retinopathy, Stargardt disease, retinitis pigmentosa, optic neuropathy, and ocular albinism. The company's core technology combines smartphone-class hardware (notably a 50 MP camera and 1440 x 3120 resolution display) with augmented-reality optics and custom software informed by neuroscience research conducted by co-founder Dr. Frank Werblin (UC Berkeley, Guggenheim Fellow) and developed in collaboration with Johns Hopkins University and funded in part by a National Eye Institute grant. Product generations include the original LIVE (2017), LIVE 2.0 (2020, discontinued 2024), IrisVision 3.0 (2023), and the Inspire 1.2 (2024), supplemented by a $649 Vision Cast HDMI streaming accessory, personal coaching services delivered by coaches who are themselves low-vision IrisVision users, and an annual extended remote support subscription at $79 per year.

The company monetizes primarily through one-time hardware device sales via its direct e-commerce channel, with quote-based pricing (not publicly disclosed), ancillary accessory revenue, coaching session bundles (non-refundable, three-month expiry), and recurring support subscriptions. Distribution is multi-channel: direct-to-consumer e-commerce with consultative inside sales, the U.S. Veterans Affairs Federal Supply Schedule, international shipping (including to Canada and Australia), and referral partnerships with organizations such as CNIB Foundation and Seva Foundation plus a network of low vision specialists. As of the most recent disclosures, approximately 3,500 individuals use IrisVision products, and the company has raised approximately $21.7 million across two SEC Reg D exempt offerings in 2021 and 2022, with a strategic partnership with Samsung Electronics America announced in 2020 to extend the technology to a global low-vision population.

Short descriptiontext

IrisVision Global, Inc. develops FDA-registered Class I wearable headsets that combine AR optics and neuroscience-based software to help individuals with macular degeneration, diabetic retinopathy, and other low-vision conditions read, recognize faces, and perform daily activities, selling primarily via direct-to-consumer e-commerce and the U.S. Veterans Affairs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPleasanton, United States
HQ citystring
Pleasanton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
low vision assistive devices, wearable medical headsets, augmented reality healthcare, vision enhancement technology, FDA registered medical devices
Industry1 code
PRIMARYHLAHAJAN
Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
NAICS code2 codes
  • Ophthalmic Goods Manufacturing339115
  • Optical Goods Retailers456130
SIC code2 codes
  • Ophthalmic Goods3851
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Low Vision Assistive Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Hardware Device Sales (LIVE 2.0)
TypeHardware Sales
Description

One-time purchase of the IrisVision wearable headset device. The LIVE 2.0 product line has been discontinued but previous versions (LIVE 1.0) and Inspire products remain available. Price is quote-based and not publicly listed on the website.

irisvision.com
2Vision Cast Accessory
TypeHardware Sales
Description

Vision Cast HDMI streaming accessory sold as an add-on for LIVE 2.0 at $649 one-time price, enabling TV/computer content streaming into the headset.

irisvision.com
3Personal Coaching Sessions
TypeProfessional Services
Description

Bundled coaching (1 free introductory session) included with device purchase, with additional coaching session bundles available for purchase separately. Coaching is non-refundable and bundles expire after 3 months.

irisvision.com
4Extended Remote Support
TypeSubscription Recurring
Description

Remote customer support available for first 6 months included with purchase. Extended support package available for purchase at $79 per additional year.

irisvision.com
5Subscriptions (Software/Service)
TypeSubscription Recurring
Description

Terms & Conditions reference subscription-based billing for certain parts of the Service, indicating recurring billing components for ongoing software services.

irisvision.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components1 value
Personnel
Pricing details3 tiers
1Vision Cast HDMI Streaming Accessory
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Vision Cast accessory priced at $649 (one-time purchase, allows streaming from TV/computer/streaming device to the headset)

irisvision.com
2Extended Remote Support
ModelSubscriptionBilling cadenceAnnual
Notes

$79 per additional year of remote support beyond the included 6-month period

irisvision.com
3Device Purchase (LIVE 2.0, LIVE 1.0, Inspire)
ModelOtherBilling cadencePay-as-you-go
Notes

Device pricing is quote-based / not publicly disclosed. Purchase includes 1 free introductory coaching session and 1-year warranty. 30-day evaluation period available for North American customers with $299 restocking fee on returns.

irisvision.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1LIVE 2.0
Description

Discontinued wearable low vision headset product line featuring 1440 x 3120 resolution, smartphone technology integration, and multiple vision modes for conditions including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.

irisvision.com
+1 more record
Core offering1 text field

IrisVision designs and sells FDA-registered Class I wearable headsets (LIVE 2.0, IrisVision 3.0, IrisVision Inspire 1.2) that combine smartphone hardware with proprietary software, augmented reality, and computer vision to help individuals with macular degeneration, diabetic retinopathy, retinitis pigmentosa, and other ocular disorders read, watch TV, recognize faces, and perform daily activities. The company offers accessories such as the Vision Cast HDMI streaming module and bundles personalized coaching services with each device.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Approximately 3,500 users worldwide
+3 more records
Product overview1 text field

IrisVision offers a portfolio of FDA-registered Class I medical wearable devices for low vision assistance. The core product line includes LIVE 2.0 (now discontinued), IrisVision 3.0, and IrisVision Inspire 1.2, which combine smartphone technology with augmented reality to help individuals with conditions like macular degeneration, diabetic retinopathy, and retinitis pigmentosa see more clearly. The ecosystem includes Vision Cast ($649 accessory) for HDMI streaming, and Personal Coaching services for remote training and support. The company was founded in 2017 and has helped approximately 3,500 users worldwide.

Product and service6 records
1IrisVision Inspire 1.2
CategoryWearable low vision headset
Description

Next-generation wearable low vision device launched in 2024, designed to help visually impaired and legally blind individuals see again using advanced vision enhancement technology.

2IrisVision 3.0
CategoryWearable low vision headset
Description

Third-generation wearable low vision headset launched in 2023, representing the next evolution in wearable vision enhancement technology for low vision patients.

3LIVE 2.0
CategoryWearable low vision headset
Description

Wearable headset-based low vision assistive device combining smartphone technology with augmented reality, featuring a 50 MP camera, Octa-core processor, 1440x3120 resolution display, and multiple vision modes. Now discontinued with warranties and support continued.

4LIVE (1.0)
CategoryWearable low vision headset
Description

Original wearable headset-based technology for low vision, introduced in 2017 as the first widely adopted headset solution for low vision. Preceded LIVE 2.0.

5Vision Cast
CategoryHardware accessory
Description

HDMI streaming accessory priced at $649 that streams content from TV, computer, or streaming devices (including Amazon Fire Stick) directly into the IrisVision headset for an immersive viewing experience.

6Personal Coaching
CategoryCoaching service
Description

Remote, personalized training and support service provided by low vision coaches who are themselves IrisVision users. Includes 1 free introductory session with additional sessions available, offered in English and Spanish via phone or video chat.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership announced to bring clinically validated vision technologies to over 200 million low vision patients globally. Dr. David C. Rhew, Chief Medical Officer at Samsung Electronics America, is quoted as a proponent of the technology, noting patients can read, watch TV, interact with people, garden, and perform daily tasks that were previously impossible. The partnership leverages Samsung's mobile hardware technology within IrisVision's wearable device platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IrisVision partnered with experts at Johns Hopkins University to develop its core technology. The collaboration contributed to the development of the neuroscience and augmented reality-based solution for low vision health. Dr. Frank Werblin's research at UC Berkeley, combined with Johns Hopkins expertise, formed the foundation of IrisVision's technology platform.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Seva Foundation partnered with IrisVision to democratize vision care through innovation. The partnership aims to expand access to low vision assistive technology globally, particularly in underserved communities.

4CNIB Foundation
Strategic tierMinorTypeGTM or Marketing Partner
Description

CNIB Foundation announced a new partnership with IrisVision to help visually impaired individuals access assistive technology. CNIB serves as a referral and advocacy partner connecting Canadian patients with IrisVision's products.

irisvision.com
5RadiusXR
Strategic tierMinorTypeOthers
Description

RadiusXR was founded by Ammad Khan, who also founded IrisVision. RadiusXR is described as a leading platform in portable vision testing technology, representing a related venture by the same founder. The companies appear to share founder and potentially overlapping technology.

irisvision.com
Strategic tierCoreTypeGTM or Marketing Partner
Description

IrisVision was awarded the Federal Supply Schedule Contract with Veterans Affairs, enabling VA hospitals and federal healthcare facilities to procure IrisVision devices for eligible veterans. The company has also developed specific programs for US Army veterans and participates in the Honor Flight program for WWII, Korean, and Vietnam veterans.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

eSight makes electronic eyewear for people with central vision loss (e.g., macular degeneration, Stargardt disease), with magnification, autofocus, and bioptic tilt features. Direct head-to-head competitor to IrisVision in the wearable low-vision assistive headset category.

TypeDirect peer
Description

OrCam MyEye and OrCam Read are AI-driven wearable assistive devices for blind and low-vision users, offering OCR, object recognition, and face recognition. Closest direct peer in vision-assistive wearable hardware, though the form factor is a clip-on rather than a headset.

TypeDirect peer
Description

NuEyes builds smart glasses for the visually impaired using augmented reality and magnification, targeting macular degeneration and other low-vision conditions. Directly competes with IrisVision's wearable headset value proposition for the same patient population.

TypeDirect peer
Description

Enhanced Vision manufactures a range of low-vision electronic magnifiers and head-worn devices (e.g., Jordy, Amigo) sold through low-vision specialists. Comparable in serving low-vision patients through clinical channels with assistive vision hardware.

TypeDirect peer
Description

HumanWare produces assistive technologies for people who are blind or have low vision, including video magnifiers and wearable solutions. Operates in an overlapping low-vision assistive device category with both retail and clinical distribution.

TypeEmerging player
Description

Envision offers AI-powered smart glasses and a mobile app that read text, describe scenes, and recognize faces for blind and low-vision users. An emerging player focused on software-first wearable AI vision assistance, with overlapping target users.

TypeEmerging player
Description

Aira provides on-demand, agent-assisted visual interpretation through smart glasses for blind and low-vision users on a subscription basis. Adjacent service-model peer with overlapping target customers but a fundamentally different human-in-the-loop delivery model.

TypeBroad incumbent
Description

Vispero, the parent of Freedom Scientific and Optelec, is a long-established leader in low-vision and blindness assistive products, including screen readers, magnifiers, and electronic video magnifiers. A broad incumbent in the same low-vision assistive category with deeper clinical distribution.

TypeBroad incumbent
Description

Samsung's Relumino mode on Galaxy devices uses VR/AR hardware and smartphone processing to deliver visual aids (magnification, color/contrast enhancement) for low-vision users. A broad incumbent threat with potential to absorb low-vision assistive features into mainstream consumer hardware.

TypeBroad incumbent
Description

Apple Vision Pro and iOS ship accessibility features (magnifier, voiceover, point-and-speak, live recognition) increasingly usable by low-vision and blind users. A broad incumbent whose mainstream spatial-computing platform could compress the dedicated-assistive-device value proposition over time.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IrisVision

Low Vision Assistive Devicesirisvision.com

IrisVision Global, Inc. develops FDA-registered Class I wearable headsets that combine AR optics and neuroscience-based software to help individuals with macular degeneration, diabetic retinopathy, and other low-vision conditions read, recognize faces, and perform daily activities, selling primarily via direct-to-consumer e-commerce and the U.S. Veterans Affairs.

What IrisVision does

IrisVision Global, Inc. is a privately held medical-device company headquartered in Pleasanton, California, that develops FDA-registered Class I wearable headsets for individuals with low vision caused by conditions such as macular degeneration, diabetic retinopathy, Stargardt disease, retinitis pigmentosa, optic neuropathy, and ocular albinism. The company's core technology combines smartphone-class hardware (notably a 50 MP camera and 1440 x 3120 resolution display) with augmented-reality optics and custom software informed by neuroscience research conducted by co-founder Dr. Frank Werblin (UC Berkeley, Guggenheim Fellow) and developed in collaboration with Johns Hopkins University and funded in part by a National Eye Institute grant. Product generations include the original LIVE (2017), LIVE 2.0 (2020, discontinued 2024), IrisVision 3.0 (2023), and the Inspire 1.2 (2024), supplemented by a $649 Vision Cast HDMI streaming accessory, personal coaching services delivered by coaches who are themselves low-vision IrisVision users, and an annual extended remote support subscription at $79 per year.

The company monetizes primarily through one-time hardware device sales via its direct e-commerce channel, with quote-based pricing (not publicly disclosed), ancillary accessory revenue, coaching session bundles (non-refundable, three-month expiry), and recurring support subscriptions. Distribution is multi-channel: direct-to-consumer e-commerce with consultative inside sales, the U.S. Veterans Affairs Federal Supply Schedule, international shipping (including to Canada and Australia), and referral partnerships with organizations such as CNIB Foundation and Seva Foundation plus a network of low vision specialists. As of the most recent disclosures, approximately 3,500 individuals use IrisVision products, and the company has raised approximately $21.7 million across two SEC Reg D exempt offerings in 2021 and 2022, with a strategic partnership with Samsung Electronics America announced in 2020 to extend the technology to a global low-vision population.

IrisVision firmographics

Firmographics
Name
IrisVision
Legal name
IrisVision Global, Inc.
Website
https://irisvision.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
IrisVision Global, Inc. develops FDA-registered Class I wearable headsets that combine AR optics and neuroscience-based software to help individuals with macular degeneration, diabetic retinopathy, and other low-vision conditions read, recognize faces, and perform daily activities, selling primarily via direct-to-consumer e-commerce and the U.S. Veterans Affairs.
Ownership category
akta.pro rank

IrisVision industry classification

Industry
Product category
Low Vision Assistive Devices
NAICS
Ophthalmic Goods Manufacturing (339115), Optical Goods Retailers (456130)
SIC
Ophthalmic Goods (3851), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAJAN
Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

Keywords

  • Low vision assistive devices
  • Wearable medical headsets
  • Augmented reality healthcare
  • Vision enhancement technology
  • FDA registered medical devices

Where IrisVision is headquartered

Location

Headquarters

HQ city
Pleasanton
HQ country
United States
HQ region
North America

Offices1 record

Markets served

IrisVision business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel

Revenue model

  1. Hardware Device Sales (LIVE 2.0): One-time purchase of the IrisVision wearable headset device. The LIVE 2.0 product line has been discontinued but previous versions (LIVE 1.0) and Inspire products remain available. Price is quote-based and not publicly listed on the website.
  2. Vision Cast Accessory: Vision Cast HDMI streaming accessory sold as an add-on for LIVE 2.0 at $649 one-time price, enabling TV/computer content streaming into the headset.
  3. Personal Coaching Sessions: Bundled coaching (1 free introductory session) included with device purchase, with additional coaching session bundles available for purchase separately. Coaching is non-refundable and bundles expire after 3 months.
  4. Extended Remote Support: Remote customer support available for first 6 months included with purchase. Extended support package available for purchase at $79 per additional year.
  5. Subscriptions (Software/Service): Terms & Conditions reference subscription-based billing for certain parts of the Service, indicating recurring billing components for ongoing software services.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goVision Cast HDMI Streaming Accessory
SubscriptionAnnualExtended Remote Support
OtherPay-as-you-goDevice Purchase (LIVE 2.0, LIVE 1.0, Inspire)

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

IrisVision product offering

Product offering

Core offering

IrisVision designs and sells FDA-registered Class I wearable headsets (LIVE 2.0, IrisVision 3.0, IrisVision Inspire 1.2) that combine smartphone hardware with proprietary software, augmented reality, and computer vision to help individuals with macular degeneration, diabetic retinopathy, retinitis pigmentosa, and other ocular disorders read, watch TV, recognize faces, and perform daily activities. The company offers accessories such as the Vision Cast HDMI streaming module and bundles personalized coaching services with each device.

Product overview

IrisVision offers a portfolio of FDA-registered Class I medical wearable devices for low vision assistance. The core product line includes LIVE 2.0 (now discontinued), IrisVision 3.0, and IrisVision Inspire 1.2, which combine smartphone technology with augmented reality to help individuals with conditions like macular degeneration, diabetic retinopathy, and retinitis pigmentosa see more clearly. The ecosystem includes Vision Cast ($649 accessory) for HDMI streaming, and Personal Coaching services for remote training and support. The company was founded in 2017 and has helped approximately 3,500 users worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • LIVE 2.0: Discontinued wearable low vision headset product line featuring 1440 x 3120 resolution, smartphone technology integration, and multiple vision modes for conditions including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
  • Inspire 1.2

Products and services

  • IrisVision Inspire 1.2 Next-generation wearable low vision device launched in 2024, designed to help visually impaired and legally blind individuals see again using advanced vision enhancement technology.
  • IrisVision 3.0 Third-generation wearable low vision headset launched in 2023, representing the next evolution in wearable vision enhancement technology for low vision patients.
  • LIVE 2.0 Wearable headset-based low vision assistive device combining smartphone technology with augmented reality, featuring a 50 MP camera, Octa-core processor, 1440x3120 resolution display, and multiple vision modes. Now discontinued with warranties and support continued.
  • LIVE (1.0) Original wearable headset-based technology for low vision, introduced in 2017 as the first widely adopted headset solution for low vision. Preceded LIVE 2.0.
  • Vision Cast HDMI streaming accessory priced at $649 that streams content from TV, computer, or streaming devices (including Amazon Fire Stick) directly into the IrisVision headset for an immersive viewing experience.
  • Personal Coaching Remote, personalized training and support service provided by low vision coaches who are themselves IrisVision users. Includes 1 free introductory session with additional sessions available, offered in English and Spanish via phone or video chat.

Quantifiable outcome

  • Approximately 3,500 users worldwide
  • +3 more outcomes

Companies that use IrisVision

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles2 records

IrisVision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature7 records

IrisVision partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Samsung Electronics AmericacoreStrategic or Co-development PartnerStrategic partnership announced to bring clinically validated vision technologies to over 200 million low vision patients globally. Dr. David C. Rhew, Chief Medical Officer at Samsung Electronics America, is quoted as a proponent of the technology, noting patients can read, watch TV, interact with people, garden, and perform daily tasks that were previously impossible. The partnership leverages Samsung's mobile hardware technology within IrisVision's wearable device platform.
  • Johns Hopkins UniversitycoreStrategic or Co-development PartnerIrisVision partnered with experts at Johns Hopkins University to develop its core technology. The collaboration contributed to the development of the neuroscience and augmented reality-based solution for low vision health. Dr. Frank Werblin's research at UC Berkeley, combined with Johns Hopkins expertise, formed the foundation of IrisVision's technology platform.
  • Seva FoundationminorStrategic or Co-development PartnerSeva Foundation partnered with IrisVision to democratize vision care through innovation. The partnership aims to expand access to low vision assistive technology globally, particularly in underserved communities.
  • CNIB FoundationminorGTM or Marketing PartnerCNIB Foundation announced a new partnership with IrisVision to help visually impaired individuals access assistive technology. CNIB serves as a referral and advocacy partner connecting Canadian patients with IrisVision's products.
  • RadiusXRminorOthersRadiusXR was founded by Ammad Khan, who also founded IrisVision. RadiusXR is described as a leading platform in portable vision testing technology, representing a related venture by the same founder. The companies appear to share founder and potentially overlapping technology.
  • Veterans Affairs (U.S.)coreGTM or Marketing PartnerIrisVision was awarded the Federal Supply Schedule Contract with Veterans Affairs, enabling VA hospitals and federal healthcare facilities to procure IrisVision devices for eligible veterans. The company has also developed specific programs for US Army veterans and participates in the Honor Flight program for WWII, Korean, and Vietnam veterans.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

IrisVision competitors and assessment

Company assessment

Direct peers

  • eSight (eSight Eyewear): eSight makes electronic eyewear for people with central vision loss (e.g., macular degeneration, Stargardt disease), with magnification, autofocus, and bioptic tilt features. Direct head-to-head competitor to IrisVision in the wearable low-vision assistive headset category.
  • OrCam (OrCam Technologies): OrCam MyEye and OrCam Read are AI-driven wearable assistive devices for blind and low-vision users, offering OCR, object recognition, and face recognition. Closest direct peer in vision-assistive wearable hardware, though the form factor is a clip-on rather than a headset.
  • NuEyes: NuEyes builds smart glasses for the visually impaired using augmented reality and magnification, targeting macular degeneration and other low-vision conditions. Directly competes with IrisVision's wearable headset value proposition for the same patient population.
  • Enhanced Vision: Enhanced Vision manufactures a range of low-vision electronic magnifiers and head-worn devices (e.g., Jordy, Amigo) sold through low-vision specialists. Comparable in serving low-vision patients through clinical channels with assistive vision hardware.
  • HumanWare: HumanWare produces assistive technologies for people who are blind or have low vision, including video magnifiers and wearable solutions. Operates in an overlapping low-vision assistive device category with both retail and clinical distribution.

Emerging players

  • Envision: Envision offers AI-powered smart glasses and a mobile app that read text, describe scenes, and recognize faces for blind and low-vision users. An emerging player focused on software-first wearable AI vision assistance, with overlapping target users.
  • Aira: Aira provides on-demand, agent-assisted visual interpretation through smart glasses for blind and low-vision users on a subscription basis. Adjacent service-model peer with overlapping target customers but a fundamentally different human-in-the-loop delivery model.

Broad incumbents

  • Vispero (Freedom Scientific / Optelec): Vispero, the parent of Freedom Scientific and Optelec, is a long-established leader in low-vision and blindness assistive products, including screen readers, magnifiers, and electronic video magnifiers. A broad incumbent in the same low-vision assistive category with deeper clinical distribution.
  • Samsung Relumino: Samsung's Relumino mode on Galaxy devices uses VR/AR hardware and smartphone processing to deliver visual aids (magnification, color/contrast enhancement) for low-vision users. A broad incumbent threat with potential to absorb low-vision assistive features into mainstream consumer hardware.
  • Apple Vision Pro (Accessibility): Apple Vision Pro and iOS ship accessibility features (magnifier, voiceover, point-and-speak, live recognition) increasingly usable by low-vision and blind users. A broad incumbent whose mainstream spatial-computing platform could compress the dedicated-assistive-device value proposition over time.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

IrisVision social profiles

Digital presence

IrisVision compliance and trust

Trust signal

Compliance1 record

IrisVision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IrisVision leadership team

Management profile

Number of profiles

Profiles9 records

IrisVision funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IrisVision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IrisVision

What does IrisVision do?

IrisVision designs and sells FDA-registered Class I wearable headsets (LIVE 2.0, IrisVision 3.0, IrisVision Inspire 1.2) that combine smartphone hardware with proprietary software, augmented reality, and computer vision to help individuals with macular degeneration, diabetic retinopathy, retinitis pigmentosa, and other ocular disorders read, watch TV, recognize faces, and perform daily activities. The company offers accessories such as the Vision Cast HDMI streaming module and bundles personalized coaching services with each device.

Is IrisVision a public or private company?

IrisVision is a private company. It is classified as venture growth investor backed and is currently operating.

When was IrisVision founded?

IrisVision was founded in 2016. It employs 51 to 100 people.

Where is IrisVision based?

IrisVision is headquartered in Pleasanton, United States, in the North America region.

How does IrisVision make money?

Five revenue lines are on record. Hardware Device Sales (LIVE 2.0) is the primary driver. The others are vision Cast Accessory, personal Coaching Sessions, extended Remote Support and subscriptions (Software/Service).

Who are IrisVision's main competitors?

Direct peers on record are eSight (eSight Eyewear), OrCam (OrCam Technologies), NuEyes, Enhanced Vision and HumanWare. Emerging players are Envision and Aira. Broad incumbents are Vispero (Freedom Scientific / Optelec), Samsung Relumino and Apple Vision Pro (Accessibility).

Does IrisVision have an API?

No public API is recorded for IrisVision.

What industry is IrisVision in?

IrisVision's product category is Low Vision Assistive Devices. Its primary akta.pro industry code is HLAHAJAN, Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids). Its NAICS code is 339115 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ForbesIrisVision Wants To Be More Than An Assistive Device For The Visually Impaired. It Wants To Diagnose And Treat Patients TooIrisVision, a Pleasanton-based startup, has developed a VR headset designed to assist visually impaired individuals with conditions such as macular degeneration and glaucoma. The company partners with Samsung for hardware manufacturing and offers the device via purchase or monthly subscription, while also planning to launch diagnostic and therapeutic features in early 2020.Business Wire BlogRadius XR, a new fashion-forward wearable technology brand, brings together multimodal diagnostics, practice management, and patient engagement for the first timeIrisVision co-founder Ammad Khan introduced Radius XR, a wearable AR/VR device combining vision diagnostics, practice management, and patient engagement. The platform enables patients to self-perform clinically equivalent vision tests, including visual field and acuity, and is available at the AAO 2022 meeting.UCHealthIrisVision: Clinical study tests whether use of technology helps to improve sightA clinical trial at the Sue Anschutz-Rodgers Eye Center is evaluating whether the IrisVision headset provides superior vision improvement compared to standard magnifying aids for young patients with low vision. The nine-month study, which has enrolled nine of its target twelve participants, assesses visual acuity, reading speed, and daily usability of the device that integrates smartphone technology. Funded by Children’s Hospital Colorado and the Ponzio Family Foundation, the research aims to determine if the adjustable digital features offer a significant advantage over fixed-magnification tools like binoculars.PR NewswireConsumer and Digital Services Executive Faiz Ahmad Joins IrisVision Board of DirectorsIrisVision, a digital vision technology company, announced that Faiz Ahmad has joined its board of directors. Ahmad currently serves as CEO of Optum Direct-to-Consumer at UnitedHealth Group and previously held senior leadership roles at Apple and Delta. The company stated that Ahmad's digital engagement expertise and consumer-focused approach will support IrisVision's expansion in digital vision healthcare.SecSEC FORM DIrisVision, Inc. filed a Form D with the Securities and Exchange Commission to report an exempt offering of securities under Rule 506(b). The filing indicates a total offering amount of $21,408,769 USD, with $11,658,797 USD already sold to 29 investors as of the first sale date in September 2021. The company is based in Pleasanton, California, and the filing was signed by CEO Ammad Khan in March 2022.VisionmondayIrisVision Unveils Streamlined, Lightweight New Design for Award-Winning Low Vision HeadsetIrisVision has launched the IrisVision Inspire, a redesigned low vision headset that reduces weight and size by tethering to an external smartphone rather than housing it internally. The device is available for purchase in the United States starting this week at a price of $3,995, which includes a 24-month cellular data contract.PR NewswireIrisVision Unveils Streamlined, Lightweight New Design for Award-Winning Low Vision HeadsetIrisVision announced the launch of IrisVision Inspire, a new low vision headset that is less than half the weight of its predecessor, achieved by tethering to a Samsung Galaxy smartphone rather than housing it internally. The Inspire platform uses award-winning smart software lens technology designed for users with low vision conditions including macular degeneration and diabetic retinopathy. The device is now available for purchase in the U.S. for $3,995 or as low as $149 per month.SecSEC FORM DIrisVision, Inc. filed a Form D with the SEC for an exempt securities offering under Rule 506(b), disclosing total offering proceeds of approximately $12.9 million. The filing lists 27 investors who have already participated in the round, which involves Series A and Series A-1 Preferred Stock as well as Common Stock.PR NewswireIrisVision Names Naeem Kayani President & Chief Operating OfficerIrisVision, a Pleasanton-based digital vision technology startup, announced the appointment of Naeem Kayani as President and Chief Operating Officer, a newly created position at the company. Kayani brings over 20 years of software business experience, having previously led transformations at CoreLogic and grown AdKnowledge to $300 million in annual revenue before raising $200 million in venture funding. The company, launched in 2017, has been expanding its platform into a cloud-based Digital Vision Clinic for remote patient monitoring and telehealth solutions.PR NewswireAI Analytics Visionary Narendra Mulani Joins IrisVision Board of DirectorsIrisVision, a digital vision technology company, announced that Narendra Mulani, former founder and Senior Managing Director of Accenture Applied Intelligence, has joined its board of directors. Mulani brings experience in AI and advanced analytics, along with existing board positions at XSell Technologies, Tredence, and the Seva Foundation. The company stated that Mulani's expertise will support its growth and mission to expand access to remote vision care and address preventable vision loss.